Member Info for Saxondale

Only been here for a few weeks , so maybe I timed this right for once . Had a few other Gold shares , one of which I exited after 18 months at a loss to plump in here . I won't mention it as sods law it will take off now , but every RNS was just pushing the jam further down the road . I'm still in another small explorer in Africa , but when I researched this company , and saw those sort of grades , and the funding situation etc , it seemed too good to be true . If we'd got an RNS with those grades over at my other share it would have blown the roof off . So fingers crossed for these guys and lets hope it becomes the success they think it will .

link removed - just google The Lancet and Coronavirus and you should find it

Hi all , this is my first post ever on LSE , been investing into Faron and a few others since last Sping , no expert and not made a fortune yet , but the bulk of my investment is now here , and one of my few picks that is showing a good profit . I could have kicked myself a few times when I should have sold and bought back in , but for better or worse I believe this share will deliver .
I wont say I'm a paid up member of the Z cult , but I have enjoyed his water off a ducks back optimism , even if he does disappear on bad days .

Up till now , I'd been thinking Traumakine was going to be playing second fiddle to Clevegen , but just read a Lancet report that came out on Fri 24th Jan regarding Coronavirus , where of those that they have identified , 29% had developed ARDS . They also said that many had been given steroids , which they seemed to think did no good , and the report actually says that they need to actively look at why steroids are even being prescribed . This ties in with Markkus comments on the previous trials . If this virus does become much more widespread , then the number of ARDs cases will be much larger , and the need for a drug that can combat it .
Heres the link
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext